P&K Skin Research Center Co., Ltd.

A347740

KR7347740003

Business Support Services

End-of-day quote Korea S.E. Other stock markets 07/05/2026			5-day change	1st Jan Change
2,385.00 ^KRW	-0.63%		-4.41%	-6.84%

06/11	P&K Skin Research Center Co., Ltd. announces Annual dividend, payable on April 17, 2026	CI
14/24/14	Tranche Update on P&K Skin Research Center Co., Ltd.'s Equity Buyback Plan announced on November 15, 2023.	CI

P&K Skin Research Center Co., Ltd. has completed an IPO in the amount of KRW 40.8639 billion.

Published on 09/04/2020 at 09:30 am IST

S&P Capital IQ

P&K SKIN RESEARCH CENTER CO., LTD.

-0.63%

DAEBONGLS.CO.,LTD.

+1.92%

P&K Skin Research Center Co., Ltd. has completed an IPO in the amount of KRW 40.8639 billion.

Security Name: Common Shares
Security Type: Common Stock
Securities Offered: 2,233,000
PriceRange: KRW 18300
Discount Per Security: KRW 549

Stocks mentioned in the article

	Add to a list 0 selected To use this feature you must be a member Log in Sign up	Approximate price	Change	5d. change	Capi.
	P&K SKIN RESEARCH CENTER CO., LTD.	2,385.00KRW	-0.63%	-4.41%	4.74Cr
	DAEBONGLS.CO.,LTD.	10,600.00KRW	+1.92%	-2.57%	8.09Cr

Latest news about P&K Skin Research Center Co., Ltd.

06/11	P&K Skin Research Center Co., Ltd. announces Annual dividend, payable on April 17, 2026	CI
14/24/14	Tranche Update on P&K Skin Research Center Co., Ltd.'s Equity Buyback Plan announced on November 15, 2023.	CI
14/24/14	Tranche Update on P&K Skin Research Center Co., Ltd.'s Equity Buyback Plan announced on November 15, 2023.	CI
14/24/14	Tranche Update on P&K Skin Research Center Co., Ltd.'s Equity Buyback Plan announced on November 15, 2023.	CI
14/24/14	Tranche Update on P&K Skin Research Center Co., Ltd.'s Equity Buyback Plan announced on November 15, 2023.	CI
14/24/14	P&K Skin Research Center Co., Ltd.'s Equity Buyback announced on November 15, 2023, has expired with 1,128,785 shares, representing 3.80% for KRW 2,996.29 million.	CI
16/24/16	Tranche Update on P&K Skin Research Center Co., Ltd.'s Equity Buyback Plan announced on November 15, 2023.	CI
15/23/15	P&K Skin Research Center Co., Ltd. announces an Equity Buyback for ¥3,000 million worth of its shares.	CI
15/23/15	P&K Skin Research Center Co., Ltd. authorizes a Buyback Plan.	CI
04/20/04	P&K Skin Research Center Co., Ltd. has completed an IPO in the amount of KRW 40.8639 billion.	CI
28/20/28	P&K Skin Research Center Co., Ltd. has filed an IPO.	CI

Chart P&K Skin Research Center Co., Ltd.

Duration

Period

Chart P&K Skin Research Center Co., Ltd.

A347740: Dynamic Chart

Company Profile

P&K Skin Research Center Co Ltd a Korea-based company mainly engaged in the business of skin human application testing. The Company provides services such as human application testing, safety tests, cosmetic efficacy tests, cosmeceuticals tests, health food tests, sensory tests, and in vitro tests. In addition, the Company perform scientific evaluations of efficacy for products applied to human skin to provide information about the products and technical support.

Employees

Sector

Business Support Services

More about the company